Jason Scott Starr DO
Gastrointestinal Cancer, Hematologic Oncology
Senior Associate Consultant, Mayo Clinic
Join to View Full Profile
4500 San Pablo Rd SJacksonville, FL 32224
Phone+1 904-953-2000
Dr. Starr is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mayo Clinic College of Medicine and Science (Jacksonville)Fellowship, Hematology and Medical Oncology, 2011 - 2014
Mayo Clinic College of Medicine and Science (Jacksonville)Residency, Internal Medicine, 2008 - 2011
Lake Erie College of Osteopathic Medicine Bradenton CampusClass of 2008
Certifications & Licensure
FL State License 2010 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Regorafenib, With Cetuximab or Panitumumab, for the Treatment of Unresectable, Locally Advanced, or Metastatic Colorectal Cancer Start of enrollment: 2020 Mar 03
Publications & Presentations
PubMed
- Burden of Comorbidities and Concomitant Medications and Their Associated Costs in Patients with Gastroenteropancreatic or Lung Neuroendocrine Tumors: Analysis of US Ad...Jennifer A Chan, Antonio Ribeiro-Oliveira Jr, Aude Houchard, Syvart Dennen, Yutong Liu
Advances in Therapy. 2025-03-13 - Onvansertib in Combination With Chemotherapy and Bevacizumab in Second-Line Treatment of-Mutant Metastatic Colorectal Cancer: A Single-Arm, Phase II Trial.Daniel H Ahn, Maya Ridinger, Timothy L Cannon, Lawrence Mendelsohn, Jason S Starr
Journal of Clinical Oncology. 2025-03-01 - 4 citationsPrimary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma.Blake J McKinley, Tucker W Coston, Jason S Starr
The Oncologist. 2025-01-17
Press Mentions
Sharing Mayo Clinic: Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 17th, 2022- Georgia Man with Neuroendocrine Cancer Gains Quality of Life Thanks to New Nuclear Med TherapyApril 14th, 2022
- New York's Cannabis Board Holds First Meeting, Amends Medical ProgramOctober 5th, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
